Frontiers Case report: Short-term eculizumab use in atypical HUS

Por um escritor misterioso

Last updated 27 abril 2025

(PDF) Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature

PDF] Atypical hemolytic uremic syndrome: a syndrome in need of clarity

PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing

Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era

Frontiers Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab

Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.

Frontiers Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis

PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing

Frontiers Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era

Optimal management of atypical hemolytic uremic disease: challenges an

Recomendado para você